Distribution and effects of intestinally administered [14C]-tyramine in cats, modified by monoamine oxidase inhibitors.
D000818:Animals; D001767:Blinking / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002415:Cats; D005260:Female; D007408:Intestinal Absorption / Q000187:drug effects*; D007668:Kidney / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D010648:Phenylacetates / Q000097:blood; D013564:Sympathetic Nervous System / Q000187:drug effects; D014439:Tyramine / Q000097:blood*
D008996:Monoamine Oxidase Inhibitors; D010648:Phenylacetates; C008070:4-hydroxyphenylacetic acid; D014439:Tyramine